第60回日本小児血液・がん学会学術集会

セッション一覧

第60回 日本小児血液・がん学会学術集会 » 一般口演

一般口演

[_OS1] 一般口演1
患児と家族の支援、疫学/統計

Oral Session 1 Support for patients and their family, Epidemiology/statistics

2018年11月14日(水) 08:30 〜 09:40 第4会場 (みやこめっせ B1F 大会議室)

座長:磯山 恵一(昭和大学藤が丘病院小児科), 角田 治美(千葉県こども病院血液腫瘍科)

Maiko Noguchi1, Hideki Nakayama1, Ryohei Yokoyama2, Keiko Shiraishi3, Yu Sakata4, Emi Ichimiya4, Tetsuko Kobayashi1, Jun Okamura1 (1.Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan, 2.Department of Orthopedics, National Kyushu Cancer Center, Fukuoka, Japan, 3.Department of Psycho-oncology, National Kyushu Cancer Center, Fukuoka, Japan, 4.Department of Pediatric ward, National Kyushu Cancer Center, Fukuoka, Japan)

Kayo Nakata1, Yuri Ito2, Winnie Magadi3, Audrey Bonaventure3, Charles Stiller4, Kota Katanoda5, Tomohiro Matsuda5, Isao Miyashiro1, Kathy Pritchard-Jones6, Bernard Rachet3 (1.Department of Cancer Strategy, Cancer Control Center, Osaka International Cancer Institute, 2.Department of Medical Statistics, Osaka Medical Collage, 3.Cancer Survival Group, London School of Hygiene & Tropical Medicine, 4.National Cancer Registration and Analysis Service, Public Health England, 5.Center for Cancer Control and Information Services, National Cancer Center, 6.Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London)

Harumi Kakuda1,4, Yukino Tatsu2, Yuriko Natsume3, Takuya Sasaki3, Arata Kimata3, Hiroko Shibanai3, Yayoi Nakajima4, Fumiko Inoue4, Norie Ueda5, Kumiko Ando1, Kazuki Furudate1, Yuichi Taneyama1, Hidemasa Ochiai1,4, Yuri Okimoto1,4, Mitsuaki Ohta2 (1.Department of Hematology/Oncology, Chiba Children’s Hospital, Chiba, Japan, 2.Department of Human and Animal-Plant Relationships, Tokyo University of AgricultureFaculty of Agriculture, Tokyo, Japan, 3.Japanese Animal Hospital Association, Tokyo, Japan, 4.Millefeuille Childhood Cancer Frontiers, Chiba, Japan, 5.Department of Nursing, Chiba Children’s Hospital, Chiba, Japan)

Hidemi Shimonodan1, Yuhki Koga2, Hideki Nakayama3,12,15, Shuichi Ozono4, Yuichi Shinkoda5, Shunsuke Nakagawa6, Yuko Nomura7, Takuya Ichimura8, Nobuyoshi Itonaga9, Sachiyo Kamimura10, Masanori Nishi11, Yasufumi Hidaka13, Noriko Hotta14, Souichi Suenobu16, Hiroshi Moritake10, Shouichi Ohga2, Yoshifumi Kawano6 (1.Department of Pediatrics, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan, 2.Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 3.Department of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, 4.Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan, 5.Department of Pediatrics, Kagoshima City Hospital, Kagoshima, Japan, 6.Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, 7.Department of Pediatrics, Fukuoka University, Fukuoka, Japan, 8.Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Japan, 9.Department of Pediatrics, Oita Prefectural Hospital, Oita, Japan, 10.Division of Pediatrics, University of Miyazaki, Miyazaki, Japan, 11.Department of Pediatrics, Saga University, Saga, Japan, 12.Department of Pediatrics, National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka, Japan, 13.Department of Pediatrics, Kitakyushu Municipal Medical Center, Kitakyushu, Japan, 14.Department of Pediatrics, Tokuyama Central Hospital, Tokuyama, Japan, 15.Department of Pediatrics, Hamanomachi Hospital, Fukuoka, Japan, 16.Division of General Pediatrics and Emergency Medicine, Department of Pediatrics, Oita University, Yufu, Japan)

Kazuki Terada1,3, Harumi Kakuda2,3, Naomi Iida3, Yayoi Nakajima3, Fumiko Inoue3, Mio Yoshino4, Yuri Okimoto2,3, Miho Maeda4 (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Department of Hematology/Oncology, Chiba Children’s Hospital, Chiba, Japan, 3.Millefeuille Childhood Cancer Frontiers, Chiba, Japan., 4.Department of Pediatrics, Nippon Medical School, Tokyo, Japan.)

一般口演

[_OS2] 一般口演2
支持療法1

Oral Session 2 Supportive care 1

2018年11月14日(水) 10:50 〜 11:50 第4会場 (みやこめっせ B1F 大会議室)

座長:田内 久道(愛媛大学医学部附属病院小児科), 森口 直彦(市立貝塚病院小児科)

Hidetaka Niizuma1, Namiko Maehara1, Saori Katayama1, Yuko Watanabe1, Masahiro Irie1, Takeshi Rikiishi1, Atsushi Kikuta2, Yoji Sasahara1, Shigeo Kure1 (1.Department of Pediatrics, Tohoku University Hospital, Sendai, Japan, 2.Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan)

Chikako Kiyotani1, Keita Terashima1,2, Yui Kimura1, Rie Ando1, Kenichi Sakamoto1, Takaki Mizuno1, Yusuke Tsumura1, Satoshi Yoshimura1, Shinichi Tsujimoto1, Kyohei Isshiki1, Yoko Shioda1, Tomoo Osumi1, Motohiro Kato1,3, Daisuke Tomizawa1,4, Kimikazu Matsumoto1 (1.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 2.Neuro-Oncology, National Center for Child Health and Development, Tokyo, Japan, 3.Division of Stem Cell Transplantation and Cellular Therapy, National Center for Child Health and Development, Tokyo, Japan, 4.Division of Leukemia/Lymphoma, National Center for Child Health and Development, Tokyo, Japan)

Takayuki Takachi1, Takayo Shoji1,2, Risa Makino1, Keisuke Urabe1, Kazuyuki Komatsu1, Koji Kawaguchi1, Taemi Ogura1, Yasuo Horikoshi1, Kenichiro Watanabe1 (1.Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan, 2.Department of General Medicine, Division of Pediatric Infectious Disease, Shizuoka Children’s Hospital, Shizuoka, Japan)

Nobuhiro Kubo1, Hiroshi Tagawa2, Chansu Shin1, Yasushi Kasahara1, Ryosuke Hosokai1, Takayuki Takachi1, Sakiko Yoshida1, Haruko Iwabuchi1, Masaru Imamura1, Akihiko Saitoh1, Chihaya Imai1 (1.Department of Pediatrics, Niigata University Medical and Dental Hospital, Niigata, Japan, 2.Division of Pharmacy, Niigata University Medical and Dental Hospital, Niigata, Japan)

Nozomu Kawashima, Shunsuke Miwata, Kotaro Narita, Shinsuke Kataoka, Motoharu Hamada, Norihiro Murakami, Daisuke Ichikawa, Kyogo Suzuki, Hironobu Kitazawa, Eri Nishikawa, Yusuke Okuno, Rieko Taniguchi, Atsushi Narita, Hideki Muramatsu, Nobuhiro Nishio, Seiji Kojima, Yoshiyuki Takahashi (Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan)

一般口演

[_OS3] 一般口演3
ALL 1

Oral Session 3 ALL 1

2018年11月14日(水) 13:00 〜 14:00 第4会場 (みやこめっせ B1F 大会議室)

座長:岡本 康裕(鹿児島大学小児科), 嶋田 博之(慶應義塾大学小児科)

Kazuki Tanimura1, Kai Yamasaki1, Yuki Okuhiro1, Kouta Hira1, Chika Nitani1, Keiko Okada1, Hiroyuki Fujisaki1, Kana Matsumoto2, Junichi Hara1 (1.Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan, 2.The Department of Pharmacy, Dosisha Women’s College)

Michinori Aoe1, Hisashi Ishida2, Takehiro Matsubara3, Shuhei Karakawa4, Hiroshi Kawaguchi4, Kaori Fujiwara2, Kiichiro Kanamitsu2, Kana Washio2, Ken Okada1, Akira Shimada2 (1.Division of Medical Support, Okayama University Hospital, Okayama, Japan, 2.Department of Pediatrics, Okayama University Hospital, Okayama, Japan, 3.Department of BioBank, Okayama University Hospital, Okayama, Japan, 4.Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan)

Toshihiko Kizuki1, Atsushi Watanabe1, Daisuke Harama1, Yasushi Murakami1, Koshi Akahane1, Kumiko Goi1, Keiko Kagami1, Masako Abe1, Kevin Urayama2,3, Takeshi Inukai1 (1.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 2.Department of Social Medicine, National Center for Child Health and Development, Tokyo, Japan, 3.Graduate School of Public Health, St.Luke’s International University)

Daiki Kato1, Atsushi Watanabe1, Daisuke Harama1, Yasushi Murakami1, Koshi Akahane1, Kumiko Goi1, Kevin Urayama2,3, Yukinori Okada4, Takeshi Inukai1 (1.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 2.National Center for Child Health and Development, Department of Social Medicine, Tokyo, Japan, 3.St, Luke’s International University, Graduate School of Public Health, 4.Osaka University, Department of Statistical Genetics)

一般口演

[_OS4] 一般口演4
ALL 2

Oral Session 4  ALL 2

2018年11月14日(水) 14:40 〜 15:40 第4会場 (みやこめっせ B1F 大会議室)

座長:今村 俊彦(京都府立医科大学小児科), 今井 千速(新潟大学医療学系小児科学分野)

Atsushi Watanabe1, Tamao Shinohara1, Shinpei Somazu1, Hiroko Saito1, Hiroko Oshiro1, Hiroki Sato1, Kazuya Takahashi1, Kumiko Goi1, Masako Abe1, Keiko Kagami1, Kunio Miyake2, Takeshi Inukai1 (1.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 2.Department of Health Sciences, University of Yamanashi, Yamanashi, Japan)

Koshi Akahane1, Atsushi Watanabe1, Kunio Miyake2, Tamao Shinohara1, Daisuke Harama1, Yasushi Murakami1, Kumiko Goi1, Kanji Sugita1, Takeshi Inukai1 (1.Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Chuo, Japan, 2.Department of Health Sciences, Graduate School of Interdisciplinary Research, University of Yamanashi, Chuo, Japan)

Tamao Shinohara1, Atsushi Watanabe1, Keiko Kagami1, Masako Abe1, Koshi Akahane1, Kumiko Goi1, Kanji Sugita1, Kevin Urayama2, Yukinori Okada3, Takeshi Inukai1 (1.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 2.Department of Social Medicine, National Center for Child Health and Development, Tokyo, Japan, 3.Osaka University, Graduate School of Medicine, Department of statistical genetics, Osaka, Japan)

Yoichi Tanaka1, Katsuyoshi Koh2, Atsushi Manabe3 (1.Department of Clinical Pharmacy, Center for Clinical Pharmacy and Sciences, School of Pharmacy, Kitasato University, Tokyo, Japan, 2.Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan, 3.Department of Pediatrics, St. Luke’s International Hospital, Tokyo, Japan)

一般口演

[_OS5] 一般口演5
神経芽腫臨床

Oral Session 5 Neuroblastoma, clinical

2018年11月14日(水) 15:50 〜 16:50 第4会場 (みやこめっせ B1F 大会議室)

座長:松本 公一(国立成育医療研究センター小児がんセンター), 米田 光宏(大阪市立総合医療センター小児外科)

Mitsuyuki Nakata1, Tomoro Hishiki2, Takehiko Kamijo3, Miki Ohira3, Atsuko Nakazawa4, Takeshi Saito1, Keita Terui1, Shugo Komatsu1, Kazuaki Harada1, Yoshitaka Shinno1, Daisuke Katsumi1, Ryoya Furugane1, Hideo Yoshida1 (1.Department of Pediatric Surgery, Chiba University, Graduate School of Medicine, Chiba, Japan, 2.Division of Surgical Oncology, National Center for Child Health and Development, Tokyo, Japan, 3.Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan, 4.Department of Clinical research, Saitama Children’s Medical center, Saitama, Japan)

Nao Takasugi1, Takayuki Mori1, Moe Hidaka1, Yuichi Mitani1, Mitsuteru Hiwatari1,2, Junko Takita1 (1.Department of Pediatrics, Tokyo University, Tokyo, Japan, 2.Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan)

Noriyuki Nishimura1, Toshiaki Ishida2, Khin Thwin1, Suguru Uemura1, Nobuyuki Yamamoto2, Akihiro Tamura2, Nanako Nino2, Aiko Kozaki2, Atsuro Saito2, Kenji Kishimoto2, Daiichiro Hasegawa2, Yoshiyuki Kosaka2, Satoru Takafuji1, Takeshi Mori1, Kazumoto Iijima1 (1.Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan, 2.Department of Hematology and Oncology, Kobe Children Hospital, Kobe, Japan)

Toshiaki Ishida1, Takayuki Ichikawa1, Naoko Nakatani1, Nanako Nino1, Sayaka Nakamura1, Nobuyuki Yamamoto1, Akihiro Tamura1, Atsuro Saito1, Aiko Kozaki1, Kenji Kishimoto1, Makiko Yoshida2, Atsufumi Kawamura3, Yoshinobu Akasaka4, Toshinori Soejima5, Daiichiro Hasegawa1, Yoshiyuki Kosaka1 (1.Department of Hematology and Oncology, Children’s Cancer Center, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan, 2.Department of Diagnostic Pathology, Children’s Cancer Center, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan, 3.Department of Neurosurgery, Children’s Cancer Center, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan, 4.Department of Diagnostic Radiology, Children’s Cancer Center, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan, 5.Department of Radiation Oncology, Children’s Cancer Center, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan)

一般口演

[_OS6] 一般口演6
神経芽腫基礎

Oral Session 6 Neuroblastoma, basic

2018年11月14日(水) 08:30 〜 09:40 第5会場 (みやこめっせ B1F 特別展示場B)

座長:永瀬 浩喜(千葉県がんセンター研究所), 義岡 孝子(国立成育医療研究センター病理診断部)

Daisuke Kaneda1, Ken Kikuchi1,2, Shigeki Yagyu1, Tomoko Iehara1, Toshiyuki Sakai3, Hajime Hosoi1 (1.Department of Pediatrics Graduate School of Medical Science Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Dept. Pediatrics, Uji Takeda hospital, Kyoto, Japan, 3.Dept. Molecular-Targeting Cancer Prevention Graduate School of Medical Science Kyoto Prefectural University of Medicine, Kyoto, Japan)

Yuki Endo1,2, Hisanori Takenobu1, Ryuichi Sugino1, Masayuki Haruta1, Kyosuke Mukae1, Shunpei Satoh1, Yoshitaka Shinno1,3, Mariko Hasegawa1,4, Ryu Okada1, Yutaka Katai1, Shaliman Dilibaerguli1, Masaki Nio2, Miki Ohira1, Takehiko Kamijo1 (1.Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan, 2.Department of Pediatric Surgery, Tohoku University, 3.Department of Pediatric Surgery, Chiba University, 4.Department of Pediatric Surgery, Dokkyo Medical University)

Miki Ohira1, Ryuichi Sugino1, Masayuki Haruta1, Hisanori Takenobu1, Tetsuya Takimoto2,10, Tomoro Hishiki2,10, Kimikazu Matsumoto2,10, Atsuko Nakazawa3,10, Hiroyuki Shichino4,10, Toshikazu Ushijima5, Yoko Nakamura6, Hiroki Nagase6,10, Tomoko Iehara7,10, Satoshi Teramukai7,10, Tatsuro Tajiri7,10, Hiroyuki Aburatani8, Akira Nakagawara9,10, Takehiko Kamijo1,10 (1.Research Institute for Clinical Oncology, Saitama Cancer Center, 2.National Center for Child Health and Development, 3.Saitama Children’s Medical Center, 4.National Center for Global Health and Medicine, 5.National Cancer Center Research Institute, 6.Chiba Cancer Center Research Institute, 7.Kyoto Prefectural University of Medicine, 8.RCAST, The University of Tokyo, 9.Saga Medical Center Koseikan, 10.Japan Children’s Cancer Group (JCCG) Neuroblastoma Committee (JNBSG))

Yuki Noguchi1, Akifumi Nakatani1, Shiina Iwai1, Yuta Suzuki1, Sae Shimada1, Masamitsu Mikami2, Katsutsugu Umeda2, Hiroshi Sugiyama3, Souichi Adachi2, Yasuhiko Kamikubo1 (1.Department of Human Health Science, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2.Department of Pediatrics, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan, 3.Department of Chemistry, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto, Japan)

Kiyohiro Ando1,2, Yoko Nakamura2, Tsugumichi Koshinaga3, Makoto Makishima1 (1.Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan, 2.Chiba Cancer Center Research Institute, 3.Division of Pediatric Surgery, Department of Surgery, Nihon University School of Medicine, Tokyo, Japan)

一般口演

[_OS7] 一般口演7
リンパ腫/免疫異常

Oral Session 7 Lymphoma/Immune disorder

2018年11月14日(水) 09:50 〜 11:00 第5会場 (みやこめっせ B1F 特別展示場B)

座長:小林 良二(札幌北楡病院小児思春期科), 金兼 弘和(東京医科歯科大学小児地域成育医療学)

Masahiro Irie1, Makoto Hitachi2, Mika Watanabe3, Saori Katayama1, Yuko Watanabe1, Hidetaka Niizuma1, Takeshi Rikiishi1, Yoji Sasahara1, Shigeo Kure1 (1.Department of Pediatrics, Tohoku University Graduate School of Medicine, 2.Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 3.Department of Pathology, Tohoku University Graduate School of Medicine)

Toshihide Yoshikawa1, Akihiko Tanizawa1,2, Koji Suzuki1, Maiko Shimada1, Yuiko Nakabayashi1, Aina Yamaguchi3, Yoshiaki Imamura3, Kunihiro Inai4, Tatsuto Shimizu5, Asami Kumano5, Yusei Ohshima1 (1.Department of Pediatrics, Faculty of Medical Sciences, University of Fukui, Fukui, Japan, 2.Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui, Japan, 3.Division of Surgical Pathology, University of Fukui Hospital, Fukui, Japan, 4.Division of Molecular Pathology, Department of Pathological Sciences, Faculty of Medical Sciences, University of Fukui, Fukui, Japan, 5.Department of Pediatrics, Fukui Prefectural Hospital, Fukui, Japan)

Hiroshi Yagasaki1, Maiko Hirai1, Hirotsugu Okuma1, Masataka Ito1, Erina Nakahara1, Motoaki Chin1, Masahiko Sugitani2, Hiroyuki Hao2, Tsubasa Okano3, Kohsuke Imai3, Tomohiro Morio3, Hide Kaneda4, Hiroyuki Kawashima4, Kensuke Oohashi4, Shuichirou Uehara4, Tsugumichi Koshinaga4, Ichiro Morioka4 (1.Department of Pediatrics, Nihon Univ, Tokyo, 2.Department of Pathlogy, Nihon Univ, Tokyo, 3.Pediatrics, Tokyo Dental and Medical Univ, Tokyo, 4.Pediatric Surgery)

Risa Takeda1, Yasuhiko Ito2, Satoru Yoshida1, Michi Kamei1, Shinji Saitoh1, Takashi Koike3, Hiromasa Yabe4, Hisashi Kato5, Hirokazu Kashiwagi5 (1.Department of Neonatology and Pediatrics, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan, 2.Department of Pediatrics, Nagoya City West Medical Center, Aichi, Japan, 3.Department of Pediatrics, Tokai University school of medicine, Kanagawa, Japan, 4.Department of Cell Transplantation and Regenerative Medicine, Tokai University school of medicine, Kanagawa, Japan, 5.Department of hematology and oncology, Osaka Univercity Graduate School of Medicine, Osaka, Japan)

Takashi Koike1, Eri Imai1, Keisuke Otsubo1, Akiko Fukumura1, Hiroyuki Mochizuki1, Hiromasa Yabe2, Risa Takeda3, Michi Kamei3, Yasuhiko Ito4, Hisashi Kato5, Hirokazu Kashiwagi5 (1.Department of Pediatrics, Tokai University school of medicine, Kanagawa, Japan, 2.Department of Cell Transplantation and Regenerative Medicine, Tokai University school of medicine, Kanagawa, Japan, 3.Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 4.Department of Pediatrics, Nagoya City West Medical Center, Nagoya, Japan, 5.Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan)

Hiroyoshi Hattori1,2, Michiko Nemoto2, Naoko Maeda1, Nobuhiro Akita1, Suzuko Moritani4, Hideki Muramatsu3, Tomonori Kawasaki4, Masami Maejima2, Hirotaka Ode2, Atsuko Hachiya2, Wataru Sugiura2, Yoshiyuki Yokomaku2, Yasumasa Iwatani2, Keizo Horibe1,2 (1.Department of Pediatrics, Nagoya Medical Center, Nagoya, Japan, 2.Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 3.Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan, 4.Department of Pathology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan)

一般口演

[_OS8] 一般口演8
骨髄増殖性疾患/MDS/JMML

Oral Session 8 Myeloproliferative disorder/MDS/JMML

2018年11月14日(水) 11:10 〜 11:50 第5会場 (みやこめっせ B1F 特別展示場B)

座長:渡邊 健一郎(静岡県立こども病院血液腫瘍科), 長谷川 大輔(聖路加国際病院小児科)

Hiroyuki Shimada1,2, Hidemitsu Kurosawa2, Akihiro Watanabe2, Masaki Ito2, Chikako Tono2, Haruko Shima2, Yuki Yuza2, Hideki Muramatsu2, Noriko Hotta2, Masahiko Okada2, Akihiko Tanizawa2 (1.Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan, 2.The CML Committee, Japan Children’s Cancer Group, Nagoya, Japan)

Yuki Yuza1, Hiroyuki Shimada2, Hidemitsu Kurosawa2, Akihiro Watanabe2, Masaki Ito2, Chikako Tono2, Haruko Shima2, Kazuko Hamamoto2, Hideki Muramatsu2, Noriko Hotta2, Masahiko Okada2, Akihiko Tanizawa2 (1.CML Committee, Japan Children’s Cancer Group, Nagoya & Department of Hematology/Oncology, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan, 2.CML Committee, Japan Children’s Cancer Group, Nagoya, Japan)

Nao Yoshida1, Kenichiro Watanabe2, Asahito Hama1, Shohei Yamamoto3, Maiko Noguchi4, Yoji Sasahara5, Hirotoshi Sakaguchi1, Yoshiko Hashii6, Atsushi Sato7, Yoshiko Atsuta8, Daiichiro Hasegawa9 (1.Department of Pediatric Hematology and Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 2.Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan, 3.Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan, 4.Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan, 5.Department of Pediatrics, Tohoku University Hospital, Sendai, Japan, 6.Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan, 7.Department of Hematology and Oncology, Miyagi Children’s Hospital, Sendai, Japan, 8.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 9.Department of Hematology and Oncology, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan)

Yuko Honda1, Yuka Nanjo2, Shinsuke Hirabayashi3, Toru Meguro4, Nao Yoshida5, Hideki Muramatsu6, Harumi Kakuda7, Shuichi Ozono8, Hiroshi Moritake9, Masahiro Yasui10, Hideki Sano11, Atsushi Manabe3, Kazuo Sakashita12 (1.Department of Pediatrics, University of Occupational and Environmental Health, Japan, 2.Department of Hematology and Oncology, Miyagi Children’s Hospital, Miyagi, Japan, 3.Department of Pediatrics, St Luke’s International Hospital, Tokyo, Japan, 4.Yamagata University Faculty of Medicine, Department of Pediatrics, Yamagata, Japan, 5.Department of Pediatric Hematology and Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 6.Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan, 7.Department of Hematology and Oncology, Chiba Children’s Hospital, Chiba, Japan, 8.Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan, 9.Division of Pediatrics Faculty of Medicine, University of Miyazaki, Miyazaki, Japan, 10.Department of Hematology and Oncology, Osaka Women’s and Children’s Hospital, Osaka, Japan, 11.Fukushima Medical University Hospital, Department of Pediatric Oncology, Fukushima, Japan, 12.Nagano Children’s Hospital, Department of Hematology and Oncology, Nagano, Japan)

一般口演

[_OS9] 一般口演9
その他の固形腫瘍

Oral Session 9 Other solid tumors

2018年11月14日(水) 13:00 〜 14:00 第5会場 (みやこめっせ B1F 特別展示場B)

座長:越永 従道(日本大学医学部小児外科), 福島 敬(筑波大学医学医療系小児科学)

Yuki Tsuji1, Yoshiaki Hirohata1, Sachi Sekine1, Katsuhisa Baba1, Yoshiko Usui1, Ayafumi Ozaki2, Takahiro Ikeda2, Akira Morimoto2, Hitoshi Osaka2, Takanori Yamagata2, Shigeru Ono1 (1.Division of Pediatric Surgery, Department of Surgery, Jichi Medical University, Tochigi, Japan, 2.Department of Pediatrics, Jichi Medical University, Tochigi, Japan)

Yuichi Shibui1,2, Ryota Souzaki1, Yoshiaki Kinoshita3, Amane Kamouchi4, Junkichi Takemoto1,2, Kenichi Kohashi2, Toshiharu Matsuura1, Yoshinao Oda2, Tomoaki Taguchi1 (1.Department of Pediatric surgery, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan, 2.Department of Anatomic Pathology, Pathological Sciences, Graduate school of Medical Sciences, Kyushu University, Fukuoka, Japan, 3.Department of Pediatric surgery, Niigata University Graduate School of Medicine, Niigata, Japan, 4.Department of Gastroenterology, Hofu Institute of Gastroenterology, Yamaguchi, Japan)

Nobu Suzuki1, Ryota Koyama1, Yasuyuki Uchida1, Kenjiro Ogushi1, Sayaka Otake1, Akira Mogi2, Ken Shirabe2 (1.Division of Pediatric Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan, 2.Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan)

Motohiro Matsui1, Atsushi Makimoto1, Shoko Yamaoka1, Yuya Saito1, Yuichi Yokokawa1, Shinichiro Shiomi2, Hideharu Shimizu2, Yasuhiro Morita2, Yutaka Yonemura3, Yuki Yuza1 (1.Department of Pediatric Hematology Oncology of Tokyo Metropolitan Children’s Medical Center, 2.Department of Surgery, Tokyo Metropolitan Tama Medical Center, 3.Peritoneal Dissemination Center, Kishiwada Tokushukai Hospital)

Masahiro Zenitani1, Gakuto Tani1, Natsumi Tanaka1, Takako Kihara2, Ikuo Matsuda2, Seiichi Hirota2, Kazuo Tamura3, Maki Kato4, Hiroki Kurahashi4, Takaharu Oue1 (1.Department of Pediatric Surgery, Hyogo college of Medicine, 2.Department of Surgical Pathology, Hyogo college of Medicine, 3.Department of Life Science, Faculty of Science and Engineering, Kinki University, 4.Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University)

一般口演

[_OS10] 一般口演10
胚細胞腫瘍1

Oral Session 10 Germ cell tumor 1

2018年11月14日(水) 14:30 〜 15:50 第5会場 (みやこめっせ B1F 特別展示場B)

座長:上原 秀一郎(日本大学医学部小児外科), 小野 滋(自治医科大学とちぎ子ども医療センター小児外科)

Etsuji Ukiyama1, Yoshiko Watanabe1, Hiroko Miya1, Hiroshi Yoshino2, Noritaka Miyazawa2, Chie Kobayashi2, Rie Ando2, Hiroshi Kamma3, Masachika Fujiwara3 (1.Department of Pediatric Surgery, Kyorin University Faculty of Medicine, Tokyo, Japan, 2.Department of Pediatrics, Kyorin University Faculty of Medicine, Tokyo, Japan, 3.Department of Pathology, Kyorin University Faculty of Medicine, Tokyo, Japan)

Reona Okada1, Moeko Hino1, Takahiro Aoki1, Yoshiharu Yamashita1, Tomoko Okunushi1, Koji Chikaraishi1, Mitsuyuki Nakata2, Takeshi Saito2, Takahiro Nakajima3, Ichiro Yoshino3, Tomoo Matsutani4, Naoki Shimojo1 (1.Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan, 2.Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan, 3.Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan, 4.Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan)

Wataru Nakamura1, Akiko Hayashi1, Sachio Fujita1, Naoyuki Miyagawa1, Fuminori Iwasaki1, Satoshi Hamanoue1, Masae Shiomi1, Shoko Goto1, Mio Tanaka2, Yukichi Tanaka2, Fumio Asano3, Norihiko Kitagawa3, Hiroaki Goto1 (1.Department of Hemato-Oncology, Kanagawa Chindren’s Medical Center, Yokohama, Japan, 2.Department of Pathology, Kanagawa Children’s Medical Center, Yokohama, Japan, 3.Department of Surgery, Kanagawa Children’s Medical Center, Yokohama, Japan)

Nobuyuki Yamamoto1, Akihiro Tamura1, Keiichi Morita2, Hironori Matsuhisa3, Naoya Morisada4, Naoko Nakatani1, Takayuki Ichikawa1, Nanako Nino1, Sayaka Nakamura1, Aiko Kozaki1, Atsuro Saito1, Kenji Kishimoto1, Toshiaki Ishida1, Daiichiro Hasegawa1, Yoshiyuki Kosaka1 (1.Department of Hematology/Oncology, Hyogo Prefectural Kobe Children’s Hospital, 2.Department of Pediatric Surgery, Hyogo Prefectural Kobe Children’s Hospital, 3.Department of Cardiovascular Surgery, Hyogo Prefectural Kobe Children’s Hospital, 4.Department of Clinical Genetics, Hyogo Prefectural Kobe Children’s Hospital)

Tetsuya Mitsunaga1, Sachie Ono1, Takashi Fumita1, Wataru Kudo1, Jun Iwai1, Harumi Kakuda2, Yuki Naruke3 (1.Department of Pediatric Surgery, Chiba Children’s Hospital, Chiba, Japan, 2.Department of Pediatric Hematology and Oncology, Chiba Children’s Hospital, Chiba, Japan, 3.Department of Diagnostic Pathology, Chiba Children’s Hospital, Chiba, Japan)

Yukino Tsukazaki1, Mitsuhiro Yoneda1, Masahumi Kamiyama1, Hiroto Yamada1, Suguru Gomi1, Satomi Nishimoto1, Kyoko Nakamura1, Toru Yorihuji2, Rie Kawakita2, Ken Inoue3, Naomi Ishi3 (1.Department of Pediatric Surgery, Osaka City General Hospital, Osaka, Japan, 2.Department of Child metabolism endocrinology, Osaka City General Hospital, Osaka, Japan, 3.Department of Pathology, Osaka City General Hospital, Osaka, Japan)

Yuhki Arai1, Masayuki Kubota1, Yoshiaki Kinoshita1, Takashi Kobayashi1, Toshiyuki Ohyama1, Naoki Yokota1, Koichi Saito1, Haruko Iwabuchi2, Chihaya Imai2, Hiroyuki Kawashima3, Yoriko Nakajima4 (1.Department of Pediatric Surgery, Niigata University Graduate School of Medical and Dental Sciences, 2.Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 3.Department of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 4.Department of Plastic and Reconstructive Surgery, Niigata University Graduate School of Medical and Dental Sciences)

一般口演

[_OS11] 一般口演11
脳腫瘍1

Oral Session 11 Brain tumor 1

2018年11月14日(水) 10:50 〜 11:50 第6会場 (みやこめっせ B1F 特別展示場A)

座長:原 純一(大阪市立総合医療センター), 古賀 友紀(九州大学医学部医学研究院地域連携小児医療学講座)

Masahiro Sugawa1, Yuki Arakawa1, Torataro Takaki1, Jun Noguchi1, Masato Yanagi1, Kiyotaka Isobe1, Makiko Mori1, Jun Kurihara2, Eiji Oguma3, Atsuko Nakazawa4, Hiroshi Kishimoto5, Katsuyoshi Koh1 (1.Department of Hematology and Oncology, Saitama Children’s Medical Center, Saitama, Japan, 2.Department of Neurosurgery, Saitama Children’s Medical Center, Saitama, Japan, 3.Department of Radiology, Saitama Children’s Medical Center, Saitama, Japan, 4.Department of Clinical Resarch, Saitama Children’s Medical Center, Saitama, Japan, 5.Department of Diagnostic Pathology, Saitama Children’s Medical Center, Saitama, Japan)

Yoshiko Nakano1, Yuko Watanabe2, Taishi Nakamura3, Ryuta Saito4, Masayuki Kanamori4, Yasuhiro Matsusaka5, Noritsugu Kunihiro5, Keiko Okada6, Junichi Hara6, Hiroaki Sakamoto5, Koichi Ichimura1 (1.Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 2.Department of Pediatrics, Tohoku University School of Medicine, 3.Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 4.Department of Neurosurgery, Tohoku University Graduate School of Medicine, 5.Department of Pediatric Neurosurgery, Osaka City General Hospital, 6.Department of Pediatric Hematology/Oncology, Osaka City General Hospital)

Kai Yamasaki1, Yoshiko Nakano4, Kazuki Tanimura1, Kouta Hira1, Yuki Okuhiro1, Chika Nitani1, Keiko Okada1, Hiroyuki Fujisaki1, Noritsugu Kunihiro2, Yasuhiro Matsusaka2, Hiroaki Sakamoto2, Hiroko Fukushima3, Takeshi Inoue3, Koichi Ichimura4, Junichi Hara1 (1.Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan, 2.Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan, 3.Department of Pathology, Osaka City General Hospital, Osaka, Japan, 4.Division of Brain Tumor Translational Research, National Cancer Research Institute, Tokyo, Japan)

Kai Yamasaki1, Yuko Watanabe2, Yuhki Koga3, Chikako Kiyotani4, Keita Terashima4, Hiroaki Goto5, Kiyotaka Isobe6, Katsuyoshi Koh6, Daiichiro Hasegawa7, Yoshiyuki Kosaka7, Junichi Hara1 (1.Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan, 2.Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan, 3.Department of Pediatrics, Kyushu University, Fukuoka, Japan, 4.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 5.Department of Hematology and Oncology, Kanagawa Children’s Medical Center, Kanagawa, Japan, 6.Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan, 7.Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 8.Department of Hematology and Oncology, Kobe Children’s Hospital, Hyogo, Japan)

一般口演

[_OS12] 一般口演12
支持療法2

Oral Session 12 Supportive care 2

2018年11月14日(水) 13:00 〜 14:00 第6会場 (みやこめっせ B1F 特別展示場A)

座長:澤田 明久(大阪府立母子医療センター血液・腫瘍科), 新小田雄一(鹿児島市立病院小児科)

Hiroaki Nagai1, Kenichiro Kobayashi2,3, Shinya Okamoto4, Hideto Ogata5, Katsutsugu Umeda5, Hidefumi Hiramatsu5, Chie Inoue1, Kumiko Honma1, Chiaki Mikami1, Takashi Nishio1, Minoru Suehiro2,3, Ikuya Usami2,3, Toshiro Maihara3, Souichi Adachi6, Tetsuo Katayama4, Tsutomu Tsujimoto1, Toshio Heike3 (1.Department of Pharmacy, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan, 2.Department of Pediatric Hematology and Oncology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan, 3.Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan, 4.Department of Pediatric Surgery, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan, 5.Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 6.Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan)

Shun Inoue1, Yukiko Oh1, Yuta Kawahara1, Kensuke Oka1, Tomomi Hayase1, Masaaki Kawada2, Hisashi Oshiro3, Naoki Masaki4, Aiko Ogawa5, Yoko Shinno6, Akira Morimoto1 (1.Department of Pediatrics, Jichi Medical University School of Medicine, 2.Department of Pediatiric and congenital Cardiovascular Surgery, Jichi Medical University, 3.Department of Pathology, Jichi Medical University, 4.Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine, 5.Department of Clinical Science, National Hospital Organization Okayama Medical Center, 6.Department of Clinical Pathology, National Hospital Organization Okayama Medical Center)

Miho Ashiarai, Naoki Umehara, Yurika Kuroko, Kaoru Yamamoto, Shunsuke Yamamoto, Rintaro Ono, Shinsuke Hirabayashi, Yosuke Hosoya, Daisuke Hasegawa, Atsushi Manabe (Department of Pediatrics, St. Luke’s international hospital, Tokyo, Japan)

Masako Inaba1, Tomohei Nakao1,2, Yumika Yoshimura3, Sho Hosaka1, Kayoko Tao1, Ryoko Suzuki1,4, Hiroko Fukushima1,4, Yuni Yamaki1, Soichiro Yamashita5,6, Masashi Mizumoto2, Hideyuki Sakurai2,7, Takashi Fukushima1,4, Hidetoshi Takada1,4 (1.Department of Pediatrics, University of Tsukuba Hospital, 2.Department of Radiation Oncology, University of Tsukuba Hospital, 3.University of Tsukuba Hospital Nursing Department, 4.Department of Child Health, Faculty of Medicine, University of Tsukuba, 5.Department of Anesthesiology and Critical Care Medicine, University of Tsukuba Hospital, 6.Department of Anesthesiology, , Faculty of Medicine, University of Tsukuba, 7.Department of Radiation Oncology, Faculty of Medicine, University of Tsukuba)

Hirozumi Sano1, Ryoji Kobayashi1, Satoru Matsushima1, Daiki Hori1, Daisuke Suzuki1, Akihiro Iguchi2, Kunihiko Kobayashi1 (1.Department of Hematology and Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan, 2.Department of Pediatrics, Hokkaido University)

一般口演

[_OS13] 一般口演13
造血細胞移植1

Oral Session 13 Hematopoietic cell transplantation 1

2018年11月14日(水) 14:10 〜 15:00 第6会場 (みやこめっせ B1F 特別展示場A)

座長:井上 雅美(大阪府立母子医療センター血液・腫瘍科), 加藤 剛二(かとう小児科・内科クリニック/名古屋第一赤十字病院)

Hideki Sano1, Kazuhiro Mochizuki1, Shogo Kobayashi1, Yoshihiro Ohara1, Nobuhisa Takahashi1, Kazuhiko Ikeda2, Hitoshi Ohto2, Atsushi Kikuta1 (1.Department of Peduatric Oncology, Fukushima Medical University Hospital, 2.Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University)

Shogo Kobayashi1, Hideki Sano1, Kazuhiro Mochizuki1, Yoshihiro Ohara1, Nobuhisa Takahashi1, Satoshi Ono2, Kazuhiko Ikeda2, Hitoshi Ohto2, Atsushi Kikuta1 (1.Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan, 2.Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan)

一般口演

[_OS14] 一般口演14
造血細胞移植2

Oral Session 14 Hematopoietic cell transplantation 2

2018年11月14日(水) 15:10 〜 16:00 第6会場 (みやこめっせ B1F 特別展示場A)

座長:矢部 普正(東海大学再生医療科学), 菊田 敦(福島県立医科大学小児腫瘍科)

Sayaka Nakamura, Kenji Kishimoto, Takayuki Ichikawa, Naoko Nakatani, Nanako Nino, Akihiro Tamura, Nobuyuki Yamamoto, Aiko Kozaki, Atsuro Saito, Toshiaki Ishida, Daiichiro Hasegawa, Yoshiyuki Kosaka (The Department of Hematology and Oncology, Kobe Children’s Hospital, Hyogo, Japan)

一般口演

[_OS15] 一般口演15
造血細胞移植3

Oral Session 15 Hematopoietic cell transplantation 3

2018年11月14日(水) 16:10 〜 17:00 第6会場 (みやこめっせ B1F 特別展示場A)

座長:高橋 義行(名古屋大学大学院医学系研究科小児科学), 西川 拓朗(鹿児島大学小児科)

Raita Araki1,2, Ryosei Nishimura3, Shintaro Mase4, Kazuhiro Noguchi2, Toshihiro Fujiki2, Rie Kuroda2, Hideaki Maeba2, Akihiro Yachie2 (1.Department of Pediatrics, Ishikawa Prefectural Central Hospital, Kanazawa, Japan, 2.Department of Pediatrics, Kanazawa University, Kanazawa, Japan, 3.Shimizu Pediatric Clinic, Takaoka, Japan, 4.Department of Pediatrics, Kouseiren Namerikawa Hospital, Namerikawa, Japan)

Masanobu Takeuchi1, Yuko Shimosato1, Masahiro Yoshitomi1, Koji Sasaki1, Norio Shiba1, Reo Tanoshima2, Chie Emoto3, Tsuyoshi Fukuda3, Shuichi Ito1 (1.Department of Pediatrics, Yokohama City University Hospital, Yokohama, Japan, 2.Pharmaceutical Outcomes Program, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada, 3.Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA)

Tomoyuki Utano1, Motohiro Kato2, Tomoo Osumi2, Yoko Shioda2, Chikako Kiyotani2, Keita Terashima2, Daisuke Tomizawa2, Kimikazu Matsumoto2, Akimasa Yamatani1 (1.Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan, 2.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan)

Atsuro Saito1, Yoshiyuki Kosaka1,2, Daiichiro Hasegawa1, Masataka Ishimura2, Nobuyuki Hyakuna2, Kazuko Kudo2, Chiai Nagae2, Hirohide Kawasaki2, Akira Ishiguro2, Midori Shima2, Masashi Taki2, Shouichi Ohga2 (1.Department of Hematology and Oncology, Kobe Children’s Hospital. Kobe, Japan, 2.Hemostasis/Thrombosis Committee, The Japanese Society of Pediatric Hematology/Oncology)

一般口演

[_OS16] 一般口演16
ALL 3

Oral Session 16  ALL 3

2018年11月15日(木) 11:10 〜 12:00 第2会場 (みやこめっせ B1F 第1展示場A)

座長:佐藤 篤(宮城県立こども病院血液腫瘍科), 後藤 裕明(神奈川県立こども医療センター血液・再生医療科)

Seishiro Nodomi1, Toshihiro Tomii2, Kenji Waki1, Toshihiko Imamura2, Tsuyoshi Imai1 (1.Department of Pediatrics, Kurashiki Central Hospital, Okayama, Japan, 2.Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan)

Takao Deguchi1, Nobutaka Kiyokawa2, Kentaro Ohki2, Atsushi Manabe3, Akiko Saito4, Keizo Horibe4 (1.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 2.Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan, 3.Department of Pediatrics, St. Luke’s International Hospital, Tokyo, Japan, 4.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan)

Takashi Ishihara1, Keiji Nogami1, Satoshi Ochi1, Toshiaki Ishida2, Yoshiyuki Kosaka2, Akihisa Sawada3, Masami Inoue3, Shinya Osone4, Toshihiko Imamura4, Hajime Hosoi4, Midori Shima1 (1.Department of Pediatrics, Nara Medical University, Nara, Japan, 2.Hyogo Prefectural Kobe Children’s Hospital Department of Hematology and Oncology, Hyogo, Japan, 3.Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, Osaka, Japan, 4.Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan)

Sae Ishimaru1,2, Yasuhiro Okamoto3, Chihaya Imai4, Hirotoshi Sakaguchi5, Tomohiko Taki6, Daisuke Hasegawa7, Yuko Cho8, Harumi Kakuda9, Hideki Sano10, Atsushi Manabe7, Toshihiko Imamura11, Motohiro Kato12, Yuki Arakawa13, Hidemi Shimonodan14, Atsushi Sato15, Souichi Suenobu16, Takeshi Inukai17, Arata Watanabe18, Yoshifumi Kawano3, Atsushi Kikuta10, Keizo Horibe19, Akira Ohara20, Katsuyoshi Koh13 (1.Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan, 2.Department of Hematology/Oncology, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan, 3.Departments of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, 4.Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 5.Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross, Nagoya First Hospital, Nagoya, Japan, 6.Department of Medical Technology, Kyorin University Faculty of Health Sciences, Tokyo, Japan, 7.Departments of Pediatrics, St. Luke’s International Hospital, Tokyo, Japan, 8.Department of Pediatrics, Hokkaido University Hospital, Sapporo, Japan, 9.Departments of Hematology/Oncology, Chiba Children’s Hospital, Chiba, Japan, 10.Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan, 11.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 12.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 13.Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan, 14.Department of Pediatrics, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan, 15.Department of Hematology and Oncology, Miyagi Children’s Hospital, Sendai, Japan, 16.Department of Pediatrics, Oita University Faculty of Medicine, Yufu, Japan, 17.Department of Pediatrics, University of Yamanashi, Kofu, Japan, 18.Department of Pediatrics, Nakadoori General Hospital, Akita, Japan, 19.Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 20.Department of Pediatrics, Toho University Omori Medical Center, Tokyo, Japan)

Keisuke Kato1,19, Hirotoshi Sakaguchi2,19, Yuichi Kodama3,19, Yuichi Shinkoda4, Akira Shimada5, Takashi Iwase6, Junko Takita7, Chitose Ogawa8, Hidefumi Hiramatsu9,19, Motohiro Kato10,19, Atsushi Sato11,19, Hideko Uryu12, Tsuyako Iwai13, Akiko Saito14, Hirohide Kawasaki15,19, Katsuyoshi Koh16, Atsushi Manabe17, Keizo Horibe14, Hiroyuki Shimada18,19 (1.Division of Pediatric Hematology and Oncology, Ibaraki Children’s Hospital, Mito, Japan, 2.Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan., 3.Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 4.Department of Pediatrics, Kagoshima City Hospital, Kagoshima, Japan., 5.Department of Pediatrics, Okayama University Hospital, Okayama, Japan., 6.Department of Pediatrics, Kagawa University Hospital, Kagawa, Japan., 7.Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 8.National Cancer Center Hospital, Tokyo, Japan, 9.Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., 10.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan., 11.Department of Hematology and Oncology, Miyagi Children’s Hospital, Miyagi, Japan., 12.Division of Pediatrics, National Center for Global health and Medicine, Tokyo, Japan., 13.Department of Pediatrics, National Hospital Organization Shikoku Medical Center for Children and Adults, Kagawa, Japan, 14.Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan., 15.Department of Pediatrics, Kansai Medical University Hirakata Hospital, Osaka, Japan., 16.Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan., 17.Department of Pediatrics, St. Luke’s International Hospital, Tokyo, Japan., 18.Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan., 19.Japan Children’s Cancer Group, Ph1ALL committee, Nagoya, Japan.)

一般口演

[_OS17] 一般口演17
再生不良性貧血

Oral Session 17 Aplastic anemia

2018年11月15日(木) 08:40 〜 09:20 第4会場 (みやこめっせ B1F 大会議室)

座長:伊藤 悦朗(弘前大学大学院医学研究科小児科学), 小原 明(東邦大学医療センター大森病院小児科)

Manabu Wakamatsu, Nobuhiro Nishio, Shunsuke Miwata, Kotaro Narita, Hironobu Kitazawa, Shinsuke Kataoka, Motoharu Hamada, Norihiro Murakami, Daisuke Ichikawa, Rieko Taniguchi, Kyogo Suzuki, Nozomu Kawashima, Eri Nishikawa, Yusuke Okuno, Atsushi Narita, Hideki Muramatsu, Seiji Kojima, Yoshiyuki Takahashi (Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.)

Eri Nishikawa, Manabu Wakamatsu, Shunsuke Miwata, Kotaro Narita, Norihiro Murakami, Shinsuke Kataoka, Motoharu Hamada, Daisuke Ichikawa, Hironobu Kitazawa, Rieko Taniguchi, Kyogo Suzuki, Nozomu Kawashima, Yusuke Okuno, Atsushi Narita, Hideki Muramatsu, Nobuhiro Nishio, Seiji Kojima, Yoshiyuki Takahashi (Department of Pediatrics, Nagoya University Graduate School of medicine, Japan)

Asahito Hama1, Daisuke Hasegawa2, Atsushi Manabe2, Kazue Nozawa3, Atsushi Narita4, Yusuke Okuno4, Hideki Muramatsu4, Yoshiyuki Takahashi4, Kenichiro Watanabe5, Akira Ohara6, Masafumi Ito7, Seiji Kojima4 (1.Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 2.Department of Pediatrics, St. Luke’s International Hospital, Tokyo, Japan, 3.Department of Laboratory Medicine, St. Luke’s International Hospital, Tokyo, Japan, 4.Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan, 5.Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan, 6.Department of Transfusion Medicine, Toho University School of Medicine, Tokyo, Japan, 7.Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan)

一般口演

[_OS18] 一般口演18
HLH/LCH

Oral Session 18 HLH/LCH

2018年11月15日(木) 10:00 〜 10:30 第4会場 (みやこめっせ B1F 大会議室)

座長:石井 榮一(愛媛大学大学院小児科学)

一般口演

[_OS19] 一般口演19
血小板/止血・血栓

Oral Session 19 Platelet disorder/Thrombosis and hemostasis

2018年11月15日(木) 10:40 〜 11:50 第4会場 (みやこめっせ B1F 大会議室)

座長:野上 恵嗣(奈良県立医科大学小児科), 河崎 裕英(関西医科大学小児科)

Chiai Nagae1, Youtarou Umezawa2, Mika Mori2, Akina Matsuoka1, Tomoko Ashikaga1, Ryo Oyama1, Dai Keino1, Atsuki Yamashita1, Tetsuya Mori1, Masashi Taki2 (1.Department of Pediatrics, St. Marianna University School of Medicin, Kawasaki, Japan, 2.Department of Pediatrics, St. Marianna University School of Medicin, Yokohama City Seibu Hospital, Yokohama, Japan)

Akira Ishiguro1, Shinji Kunishima2, Yoji Sasahara3, Osamu Ohara4, Kenichi Imadome5, Kenichiro Hata5, Tadashi Kaname5, Yoichi Matsubara5, Platelet Committee6 (1.Center for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan, 2.Department of Medical Technology, Gifu University of Medical Science, Gifu, Japan, 3.Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan, 4.Kazusa DNA Research Institute, Kisarazu, Japan, 5.Research Institute, National Center for Child Health and Development, Tokyo, Japan, 6.Japanese Society of Pediatric Hematology/Oncology, Japan)

Yoji Sasahara1, Shinji Kunishima2, Masue Imaizumi3, Yukihiro Takahashi4, Akira Ishiguro5, Platelet Committee6 (1.Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan, 2.Department of Medical Technology, School of Health Science, Gifu University of Medical Science, Gifu, Japan, 3.Department of Hematology and Oncology, Miyagi Children’s Hospital, Miyagi, Japan, 4.Nara Red Cross Blood Center, Nara, Japan, 5.Department of Hematology, National Center for Child Health and Development, Tokyo, Japan, 6.Platelet Committee, Japanese Society of Pediatric Hematology and Oncology, Japan)

一般口演

[_OS20] 一般口演20
肝腫瘍

Oral Session 20 Hepatic tumor

2018年11月15日(木) 13:10 〜 13:50 第4会場 (みやこめっせ B1F 大会議室)

座長:田中 祐吉(神奈川県立こども医療センター), 井田 孔明(帝京大学医学部附属溝口病院小児科)

Akiyoshi Nomura1, Koji Fukumoto1, Masaya Yamoto1, Toshiaki Takahashi1, Kengo Nakaya1, Akinori Sekioka1, Yutaka Yamada1, Koji Kawaguchi2, Kenichiro Watanabe2, Naoto Urushihara1 (1.Department of Pediatric Surgery, Shizuoka Children’s Hospital, Shizuoka, Japan, 2.Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan)

Akihiro Tamura1, Makiko Yoshida2, Nobuyuki Yamamoto1, Nanako Nino1, Takayuki Ichikawa1, Naoko Nakatani1, Sayaka Nakamura1, Atsuro Saito1, Aiko Kozaki1, Kenji Kishimoto1, Toshiaki Ishida1, Hiroaki Fukuzawa3, Akiko Yokoi3, Kosaku Maeda3, Daiichiro Hasegawa1, Eiso Hiyama1, Yoshiyuki Kosaka1 (1.Dpartment of Hematology and Oncology, Kobe Children’s Hospital, Kobe, Japan, 2.Department of Diagnostic Pathology, Kobe Children’s Hospital, Kobe, Japan, 3.Department of Pediatric Surgery, Kobe Children’s Hospital, Kobe, Japan, 4.Department of Pediatric Surgery, Hiroshima University Hospital)

Fumito Yamazaki1,2, Atsuko Nakazawa3, Yoshiko Nakano4, Miki Ohira5, Takako Yoshioka6, Motohiro Kato7, Chitose Ogawa8, Koichi Ichimura4, Takehiko Kamijo5, Tomoro Hishiki9, Hitoshi Ichikawa1 (1.Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan, 2.Keio University, Graduate School of Medicine, Tokyo, Japan, 3.Department of Clinical Research, Saitama Children’s Medical Center, Saitama, Japan, 4.Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan, 5.Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan, 6.Department of Pathology, National Center for Child Health and Development, Tokyo, Japan, 7.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 8.Department of Pediatric Oncology, National Cancer Center Central Hospital, Tokyo, Japan, 9.Department of Pediatric Surgical Oncology, National Cancer Center Central Hospital, Tokyo, Japan)

一般口演

[_OS21] 一般口演21
外科治療

Oral Session 21 Surgical treatment

2018年11月15日(木) 14:00 〜 15:00 第4会場 (みやこめっせ B1F 大会議室)

座長:田口 智章(九州大学大学院医学研究院小児外科学分野), 仁尾 正記(東北大学大学院小児外科学分野)

Maho Inoue1, Shigehisa Fumino1, Mayumi Higashi1, Taizo Furukawa1, Tatsuro Tajiri1, Toshihiko Imamura2, Hajime Hosoi2 (1.Department of Pediatric surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan)

一般口演

[_OS22] 一般口演22
その他の固形腫瘍2

Oral Session 22 Other solid tumors 2

2018年11月15日(木) 15:10 〜 16:00 第4会場 (みやこめっせ B1F 大会議室)

座長:窪田 正幸(新潟大学大学院小児外科), 渕本 康史(国際医療福祉大学医学部小児外科)

Kumie Yamaashi1, Takashi Fukushima1,2, Kayoko Tao1, Tomohei Nakao1,3, Hiroko Fukushima1,2, Ryoko Suzuki1,2, Yuni Yamaki1, Sho Hosaka1, Masayuki Nakano4, Shingo Sakashita4,5, Ayumu Arakawa6, Chitose Ogawa6, Akihiko Yoshida7, Taisuke Mori7, Hidetoshi Takada1,2 (1.Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan, 2.Department of Child Health, Faculty of Medicine, University of Tsukuba, 3.Department of Radiation Oncology, University of Tsukuba Hospital, 4.Department of Diagnostic Pathology, University of Tsukuba Hospital, 5.Department of Diagnostic Pathology, Faculty of Medicine, University of Tsukuba, 6.Department of Pediatric Oncology, National Cancer Center Hospital, 7.Department of Pathology and Clinical Laboratories, National Cancer Center Hospital)

Daisuke Ichikawa, Hideki Muramatsu, Yusuke Okuno, Manabu Wakamatsu, Shunsuke Miwata, Kotaro Narita, Hironobu Kitazawa, Motoharu Hamada, Shinsuke Kataoka, Rieko Taniguchi, Norihiro Murakami, Kyogo Suzuki, Eri Nishikawa, Nozomu Kawashima, Atsushi Narita, Nobuhiro Nishio, Seiji Kojima, Yoshiyuki Takahashi (Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Shunsuke Miwata, Atsushi Narita, Manabu Wakamatsu, Kotaro Narita, Hironobu Kitazawa, Shinsuke Kataoka, Motoharu Hamada, Norihiro Murakami, Rieko Taniguchi, Daisuke Ichikawa, Kyogo Suzuki, Nozomu Kawashima, Eri Nishikawa, Yusuke Okuno, Nobuhiro Nishio, Hideki Muramatsu, Seiji Kojima, Yoshiyuki Takahashi (Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Yuji Yamada1,2,3, Shota Kato4, Ryota Shirai1, Tomoo Osumi1,2, Chikako Kiyotani2, Toshihiko Watanabe5, Tomoro Hishiki6, Masahiro Sekiguchi4, Masafumi Seki4, Junko Takita4, Nobutaka Kiyokawa1, Osamu Miyazaki7, Takako Yoshioka8, Kimikazu Matsumoto2, Motohiro Kato1,2 (1.Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan, 2.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 3.Department of Pediatrics, Saitama City Hospital, Saitama, Japan, 4.Department of Pediatrics, The University of Tokyo, Tokyo, Japan, 5.Division of Surgery, National Center for Child Health and Development, Tokyo, Japan, 6.Division of Surgical Oncology, National Center for Child Health and Development, Tokyo, Japan, 7.Department of Radiology, National Center for Child Health and Development, Tokyo, Japan, 8.Department of Pathology, National Center for Child Health and Development, Tokyo, Japan)

Tamaki Ueda1, Yuhki Koga1, Kanako Ishii1, Motoshi Sonoda1, Kentaro Nakashima1, Mitsuharu Fukazawa2, Kenichi Kohashi3, Yoshinao Oda3, Michio Ozeki4, Yoko Aoki5, Shouichi Ohga1 (1.Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2.Fukuoka Children Hospital, Fukuoka, Japan, 3.Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 4.Department of Pediatrics, Gifu University Hospital, Gifu, Japan, 5.Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan)

一般口演

[_OS23] 一般口演23
脳腫瘍2

Oral Session 23 Brain tumor 2

2018年11月15日(木) 10:00 〜 11:20 第5会場 (みやこめっせ B1F 特別展示場B)

座長:清谷 知賀子(国立成育医療研究センター小児がんセンター), 橋井 佳子(大阪大学大学院医学系研究科小児科)

Keiji Tasaka1, Katsutsugu Umeda1, Tatsuya Kamitori1, Hideto Ogata1, Takashi Mikami1, Itaru Kato1, Hidefumi Hiramatsu1, Yoshiki Arakawa2, Michio Noguchi3, Souichi Adachi4, Junko Takita1 (1.Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2.Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3.Medical Innovation center, Kyoto University Graduate School of Medicine, Kyoto, Japan, 4.Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan)

Daiki Yamashita1, Daichi Sajiki1, Ryo Maemura1, Ayako Yamamori1, Hirotoshi Sakaguchi1, Nao Yoshida1, Hisashi Hatano2, Hiroyuki Ogino3, Asahito Hama1 (1.Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 2.Department of Neurosurgery, Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 3.Department of Proton Therapy, Nagoya City West Medical Center, Aichi, Japan)

Naoki Tsuboya1, Junya Hirayama1, Takahide Kokumai1, Tomoki Hattori1, Takahiro Ito1, Norihito Mamiya1, Keishiro Amano1, Hidemi Toyoda1, Shotaro Iwamoto1, Hiroki Hori1, Akinori Takada2, Noriko Ii3, Masahiro Hirayama1 (1.Department of Pediatrics, Mie University Hospital, Mie, Japan, 2.Department of Radiation Oncology, Mie University Hospital, Mie, Japan, 3.Department of Radiation Oncology, Japanese Red Cross Ise Hospital, Mie, Japan)

Atsufumi Kawamura1, Akihiro Tamura2, Nobuyuki Yamamoto2, Kenji Kishimoto2, Toshiaki Ishida2, Daiichiro Hasegawa2, Yoshiyuki Kosaka2, Toshinori Soejima3 (1.Department of Neurosurgery, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan, 2.Department of Hematology and Oncology, Hyogo Prefectural Kobe Children’s Hospital Kobe, Japan, 3.Department of Radiation Oncology, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan)

Kazuyuki Komatsu1, Risa Makino1, Keisuke Urabe1, Koji Kawaguchi1, Takayuki Takachi1, Taemi Ogura1, Yasuo Horikoshi1, Hideto Iwafuchi2, Takafumi Wataya3, Ryuji Ishizaki3, Yuzuru Tashiro3, Kenichiro Watanabe1 (1.Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan, 2.Department of Pathology, Shizuoka Children’s Hospital, Shizuoka, Japan, 3.Department of Neurosurgery, Shizuoka Children’s Hospital, Shizuoka, Japan)

Maki Taniguchi1, Shuhei Karakawa1, Maiko Shimomura1, Yutaka Kato1, Hiroshi Kawaguchi1, Fumiyuki Yamasaki2, Masao Kobayashi1 (1.Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan, 2.Department of Neurosurgery, Hiroshima University Hospital, Hiroshima, Japan)

Naoki Kagawa1, Chisato Yokota1, Takamune Achiha1, Toru Umehara1, Hideyuki Arita1, Yasunori Fujimoto1, Haruhiko Kishima1 (1.Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan, 2.Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan)

一般口演

[_OS24] 一般口演24
萌芽的研究、独創的研究

Oral Sesson 24 Exploratory and innovative research

2018年11月15日(木) 11:30 〜 12:00 第5会場 (みやこめっせ B1F 特別展示場B)

座長:盛武 浩(宮崎大学医学部小児科)

Fumiko Chiba1, Tsunao Kishida2, Kouji Masumoto1, Tatsuro Tajiri3, Osamu Mazda2 (1.Department of Pediatric Surgery, University of Tsukuba, Tsukuba, Japan, 2.Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan)

Junnosuke Maniwa1,2, Koseki Kimura1, Shigehisa Fumino1, Tomoko Tanaka1, Mayumi Higashi1, Kohei Sakai1, Shigeyoshi Aoi1, Taizo Furukawa1, Tsunao Kishida2, Osamu Mazda2, Tatsuro Tajiri1 (1.Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, 2.Department of Immunology, Kyoto Prefectural University of Medicine)

一般口演

[_OS25] 一般口演25
緩和治療

Oral Session 25 Palliative treatment

2018年11月15日(木) 13:10 〜 14:10 第5会場 (みやこめっせ B1F 特別展示場B)

座長:天野 功二(あおぞら診療所しずおか), 早川 晶(淀川キリスト教病院緩和医療内科)

Yuhki Koike1,2,3, Yuka Nagano1, Kohei Matsushita1, Keishiro Amano2, Kohei Otake3, Mikihiro Inoue1, Masahiro Hirayama2, Keiichi Uchida1 (1.Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan, 2.Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Mie, Japan, 3.Department of Surgery, Mie Prefectural General Medical Center, Yokkaichi, Mie, Japan)

Kenji Kishimoto1,2, Noriko Sekiguchi1, Noriyuki Ikejima1, Aiko Kozaki1,2, Kohei Norimatsu1, Miu Fujii1, Yuki Tsukada1, Fumi Nakatani1, Kazumi Ozawa1, Daiichiro Hasegawa2, Atsufumi Kawamura3, Yoshiyuki Kosaka2 (1.Palliative Care Team, Children’s Cancer Center, Kobe Children’s Hospital, Kobe, Japan, 2.Department of Hematology & Oncology, Kobe Children’s Hospital, Kobe, Japan, 3.Department of Neurosurgery, Kobe Children’s Hospital, Kobe, Japan)

Hideto Ogata1, Itaru Kato1, Megumi Uto2, Tatsuya Kamitori1, Keiji Tasaka1, Takashi Mikami1, Katsutsugu Umeda1, Hidefumi Hiramatsu1, Daisuke Fukao3, Keigo Hamahata3, Takashi Mizowaki2, Souichi Adachi4, Junko Takita1 (1.Department of pediatrics, Graduate School of medicine, Kyoto University, Kyoto, Japan, 2.Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3.Department of pediatrics of Japanese Red Cross Wakayama Medical Center, 4.Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan)

Ayumu Arakawa1, Chitose Ogawa1, Hiroto Ishiki2, Mariko Shimizu3, Nami Shirakawa1, Tomoko Sonoda1, Sae Ishimaru1, Miho Nakajima1, Tadashi Kumamoto1, Eriko Satomi2,3 (1.Department of Pediatric Oncology, National Cancer Center Hospital, 2.Department of Palliative Medicine, National Cancer Center Hospital, 3.Center for Physician Referral and Medical Social service, National Cancer Center Hospital)

Rie Kanai1, Keiko Oota2, Hiroto Tsumura3, Makoto Okuno4, Akira Yamanoi5, Tatsurou Mikawwa6 (1.Department of Pediatrics, Faculty of Medicine, SHIMANE University, Shimane, Japan, 2.Reginal cooperation office, Shimane University Hospital, 3.Tsumura Family Clinic, 4.Home Clinic DAN, 5.Iwami Clinic, 6.Homeclinic Manenoki)

Nobuyuki Yotani1, Daisuke Shinjo2, Kiyohide Fushimi4, Kimikazu Matsumoto3 (1.Department of Palliative Medicine, National Center for Child Health and Development, 2.Department of Information Technology and Management, National Center for Child Health and Development, 3.Children’s Cancer Center, National Center for Child Health and Development, 4.Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School)

一般口演

[_OS26] 一般口演26
脳腫瘍外科

Oral Session 26 Brain tumor surgery

2018年11月15日(木) 14:20 〜 15:30 第5会場 (みやこめっせ B1F 特別展示場B)

座長:西川 亮(埼玉医科大学国際医療センター), 坂本 博昭(大阪市立大学大学院医学研究科脳神経外科学)

Takumi Yamanaka1, Yoshinobu Takahashi1, Seisuke Tanigawa1, Michiko Takado1, Daisuke Umebayashi1, Masataka Nanto1, Kazunori Tatsuzawa1, Hiroyasu Sasajima1, Hajime Hosoi2, Naoya Hashimoto1 (1.Department of Neurosurgery, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan, 2.Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan)

Fumiyuki Yamasaki1, Yasuyuki Kinoshita1, Takeshi Takayasu1, Satoshi Usui1, Motoki Takano1, Ushio Yonezawa1, Atsushi Tominaga3, Kazuhiko Sugiyama2, Kaoru Kurisu1 (1.Department of Neurosurgery, Hiroshima University Hospital, Hiroshima, Japan, 2.Department of Clinical Oncology & Neuro-oncology Program, Hiroshima University Hospital, Hiroshima, Japan, 3.Department of Neurosurgery, Hiroshima Prefectural Hospital, Hiroshima, Japan)

Kenichi Usami1, Keita Terashima2, Yui Kimura2, Eitarou Ishisaka1, Ako Matsuhashi1, Hideki Ogiwara1 (1.Division of Neurosurgery, National Center for Child Health and Development, Tokyo, Japan, 2.Division of Neuro-Oncology, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan)

Tadashi Miyagawa1, Minami Sasaki2, Hirosi Kikuchi2, Mariko Yabuki2, Yoshiyuki Watanabe2, Koichi Tamaki2, Hirohide Karasudani2, Akira Yamaura2 (1.Department of Pediatric Neurosurgery, Matsudo City General Hospital, Chiba, Japan, 2.Department of Neurosurgery, Matsudo City General Hospital, Chiba, Japan)

一般口演

[_OS27] 一般口演27
AML

Oral Session 27 AML

2018年11月16日(金) 13:10 〜 13:50 第2会場 (みやこめっせ B1F 第1展示場A)

座長:多賀 崇(滋賀医科大学小児科), 足立 壯一(京都大学大学院医学研究科人間健康科学系専攻)

Taeko Kaburagi1, Genki Yamato1, Yusuke Hara2, Norio Shiba3, Kentaro Ohki4, Manabu Sotomatsu1, Akira Shimada5, Daisuke Hasegawa6, Atsushi Manabe6, Yasuhide Hayashi7 (1.Department of Hematology/Oncology, Gunma Children’s Medical Center, Gunma, Japan, 2.Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan, 3.Department of Pediatrics, Yokohama City University Hospital, Kanagawa, Japan, 4.Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan, 5.Department of Pediatrics, Okayama University, Okayama, Japan, 6.Department of Pediatrics, St. Luke’s International Hospital, Tokyo, Japan, 7.Institute of Physiology and Medicine, Jobu University, Gunma, Japan)

Kenichi Sakamoto1,2,3, Norio Shiba4, Takao Deguchi1,5, Nobutaka Kiyokawa6, Yoshiko Hashii7, Akiko Saito3, Daisuke Tomizawa1, Takashi Taga8, Souichi Adachi9, Toshihiko Imamura2 (1.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 2.Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.National Hospital Organization, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 4.Department of Pediatrics, Yokohama City University Hospital, Graduate School of Medicine, Yokohama, Japan, 5.Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan, 6.Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan, 7.Department of Pediatrics, Osaka University, Osaka, Japan, 8.Department of Pediatrics, Shiga Medical University, Otsu, Shiga, Japan, 9.Department of Human Health Science, Kyoto University, Kyoto, Japan)

一般口演

[_OS28] 一般口演28
横紋筋肉腫・骨軟部肉腫

Oral Session 28 Rhabdomyosarcoma・Bone soft tissue sarcoma

2018年11月16日(金) 10:00 〜 11:00 第4会場 (みやこめっせ B1F 大会議室)

座長:陳 基明(日本大学医学部小児科学系小児科学分野), 小川 淳(新潟県立がんセンター新潟病院小児科)

Tamae Kugai1, Yuichi Mitani2, Yasuo Kodachi2, Jun Fujishiro3, Nao Takasugi2, Keita Hogetsu2, Moe Hidaka2, Mitsuteru Hiwatari1, Junko Takita2 (1.Department of Cell Therapy and Transplantation Medicine, University of Tokyo, Tokyo, Japan, 2.Department of Pediatrics, The University of Tokyo, Tokyo, Japan, 3.Deparment of Pediatric Surgery, The University of Tokyo, Tokyo, Japan)

Tetsuko Kobayashi1, Maiko Noguchi1, Hideki Nakayama1, Shouichi Ohga2 (1.Division of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan, 2.Department of Pediatrics, Kyushu University Hospital, Fukuoka, Japan)

Nao Takasugi1, Moe Hidaka1, Yuichi Mitani1, Mitsuteru Hiwatari1,2, Chizue Uotani3, Kan Suzuki3, Jun Fujishiro3, Junko Takita1 (1.Department of Pediatrics, University of Tokyo, Tokyo, Japan, 2.Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan, 3.Department of Pediatric Surgery, University of Tokyo, Tokyo, Japan)

Yuji Ishida1, Hironobu Kitazawa1,4, Kotaro Narita1,4, Hirohisa Katagiri2, Hideki Murata2, Jyunji Wasa2, Mitsuru Tkahasi2, Hideyuki Harada3, Shigeyuki Muramaya3, Naomasa Hayashi5 (1.Department of Pediatrics, Shizuoka Cancer Center, Shizuoka, Japan, 2.Department of Orthopedic surgery, Shizuoka Cancer Center, Shizuoka, Japan, 3.Center of proton and radiation therapy, 4.Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan, 5.Department of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan)

Hiroyoshi Watanabe1, Kazumi Okamura1, Keita Osumi1, Yuko Ichihara1, Yuki Morimoto2, Koichi Tsuneyama2, Syoji Kagami1 (1.Department of Pediatrics, Graduate school of Biomedical sciences Tokushima University, Tokushima, Japan, 2.Department of Pathology and Laboratory Medicine, Graduate school of Biomedical sciences Tokushima University, Tokushima, Japan)

一般口演

[_OS29] 一般口演29
骨肉腫

Oral Session 29 Osteosarcoma

2018年11月16日(金) 11:10 〜 11:50 第4会場 (みやこめっせ B1F 大会議室)

座長:家原 知子(京都府立医科大学大学院医学研究科小児科学), 小川千登世(国立研究開発法人国立がん研究センター中央病院小児腫瘍科)

Sachiyo Kamimura1, Ai Yamada1, Mariko Kinoshita1, Daisuke Sawa1, Yusuke Saito1, Hiroshi Ikejiri2, Takero Sakamoto2, Etsuo Chosa2, Norihiko Kitagawa3, Hiroshi Moritake1 (1.Division of Pediatrics, University of Miyazaki, Miyazaki, Japan, 2.Division of Orthopaedic Surgery, University of Miyazaki, Miyazaki, Japan, 3.Department of Surgery, Kanagawa Children’s Medical Center, Kanagawa, Japan)

Ryo Akazawa1, Katsutsugu Umeda1, Keiji Tasaka1, Tatsuya Kamitori1, Itaru Kato1, Hidefumi Hiramatsu1, Akio Sakamoto2, Takeshi Okamoto2, Souichi Adachi3, Junko Takita1 (1.Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2.Department of Orthopedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3.Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan)

一般口演

[_OS30] 一般口演30
晩期合併症

Oral Session 30 Late effect

2018年11月16日(金) 13:10 〜 13:50 第4会場 (みやこめっせ B1F 大会議室)

座長:末延 聡一(大分大学小児科大分こども急性救急疾患学部門医療・研究事業), 清谷 知賀子(国立成育医療研究センター小児がんセンター)

Atsuko Watanabe1, Atsuhiko Ohta1, Takashi Fujino2, Yuko Akioka3, Junki Koike4, Ryuhei Tanaka1 (1.Department of Pediatric Oncology, International Medical Center, Saitama Medical University, Saitama, Japan, 2.Department of Pathology, International Medical Center, Saitama Medical University, Saitama, Japan, 3.Department of Pediatrics, Saitama Medical University, 4.Deparitment of Pathology, Kawasaki Municipal Tama Hospital, Kanagawa, Japan)

Yasushi Ishida1, Miho Maeda2, Jun Okamura3, Hiroshi Kawaguchi4, Maho Sato5, Mika Tokuyama6, Chikako Kiyotani7, Hiroki Hori8, Ryoji Kobayashi9, Tatsuo Kuroda10 (1.Pediatric Medical Center, Ehime Prefectural Central Hospital, 2.Department of Pediatrics, Nippon Medical School, 3.Department of Pediatrics, National Kyushu Cancer Center, 4.Department of Pediatrics, Hiroshima University Hospital, 5.Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, 6.Division of Hematology and Oncology, Shizuoka Children’s Hospital, 7.Children Cancer Center, National Center for Child Health and Development, 8.Department of Pediatrics, Mie University Graduate School of Medicine, 9.Department of Pediatrics, Sapporo Hokuyu Hospital, 10.Department of Pediatric Surgery, Keio University School of Medicine)

一般口演

[_OS31] 一般口演31
新規治療

Oral Session 31 New treatment

2018年11月16日(金) 13:10 〜 13:40 第6会場 (みやこめっせ B1F 特別展示場A)

座長:滝 智彦(杏林大学保健学部臨床検査技術学科)

Mari Sonoda1, Katsutsugu Umeda2, Seishiro Nodomi2, Satoshi Obu2, Satoshi Saida2, Itaru Kato2, Hidefumi Hiramatsu2, Eri Ogawa1, Shinya Okamoto3, Ken Morita4, Yasuhiko Kamikubo4, Souichi Adachi4, Tatsutoshi Nakahata5, Hideaki Okajima1, Shinji Uemoto1, Junko Takita2, Toshio Heike2 (1.Department of Pediatric Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2.Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3.Department of Pediatric Surgery, Amagasaki General Medical Center, Hyogo, Japan, 4.Department of Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 5.Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan)

Sachiko Sakai1, Fuminori Kimura2,4, Takashi Taga3, Hisataka Kato1, Yuki Kawai1,4, Tomoharu Shimizu1,4, Yuhachi Ikeda3, Takashi Kigawa3, Masaji Tani1 (1.Department of Surgery, Shiga University of Medical Science, Shiga, Japan, 2.Department of Obstetrics and Gynecology, Shiga University of Medical Science, Shiga, Japan, 3.Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan, 4.Oncofertility Network Shiga, Shiga, Japan)